Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 105-113

  Cass, Wayne A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ASCORBIC ACID; DOPAMINE; METHAMPHETAMINE; POTASSIUM; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; MALE; MICRODIALYSIS; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; MALE; METHAMPHETAMINE; MICRODIALYSIS; POTASSIUM; RATS; RATS, INBRED F344; SEROTONIN;

EID: 0030937126     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. BITTNER, S. E., WAGNER, G. C., AIGNER, T. G. AND SEIDEN, L. S.: Effects of high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats. Pharmacol. Biochem. Behav. 14: 481-486, 1981.
2. BOWYER, J. F., DAVIES, D. L., SCHMUED, L., BROENING, H. W., NEWPORT, G. D., SLIKKER, W., JR. AND HOLSON, R. R.: Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268: 1571-1580, 1994.
3. BOWYER, J. F., TANK, A. W., NEWPORT, G. D., SLIKKER, W., JR., ALI, S. F. AND HOLSON, R. R.: The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260: 817-824, 1992.
4. BRUNSWICK, D. J., BENMANSOUR, S., TEJANI-BUTT, S. M. AND HAUPTMANN, M.: Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse 11: 287-293, 1992.
5. CASS, W. A. AND GERHARDT, G. A.: Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176: 259-263, 1994.
6. CASS, W. A., GERHARDT, G. A., MAYFIELD, R. D., CURELLA, P. AND ZAHNISER, N. R.: Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J. Neurochem. 59: 259-266, 1992.
7. CASS. W. A., ZAHNISER, N. R., FLACH, K. A. AND GERHARDT, G. A.: Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: Role of metabolism and effects of locally applied uptake inhibitors. J. Neurochem. 61: 2269-2278, 1993.
8. EISCH, A. J., GAFFNEY, M., WEIHMULLER, F. B., O'DELL, S. J. AND MARSHALL, J. F.: Striatal subregiona are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res. 598: 321-326, 1992.
9. FINNEGAN, K. T., RICAURTE, G., SEIDEN, L. S. AND SCHUSTER, C. R.: Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine. Psychopharmacology 77: 43-52, 1982.
10. FRIEDEMANN, M. N. AND GERHARDT, G. A.: Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol. Aging 13: 325-332, 1992.
11. GARRIS, P. A. AND WIGHTMAN, R. M.: Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: An in vivo voltammetric study. J. Neurosci. 14: 442-450, 1994.
12. GERHARDT, G. A., CASS, W. A., HENSON, M., ZHANG, Z., OVADIA, A., HOFFER, B. J. AND GASH, D. M.: Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey. Neurobiol. Aging 16: 939-946, 1995.
13. GERHARDT, G. A., OKE, A. F., NAGY, G., MOGHADDAM, B. AND ADAMS, R. N.: Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. 290: 390-395, 1984.
14. GERHARDT, G. A., PANG. K. AND ROSE, G. M.: In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus J. Pharmacol. Exp. Ther. 241: 714-721, 1987.
15. GIBB, J. W., HANSON, G. R. AND JOHNSON, M.: Neurochemical mechanisms of toxicity. In Amphetamine and Its Analogs: Psychopharmacology, Toxicology, and Abuse, ed. by A. K. Cho and D. S. Segal, pp. 269-295, Academic Press, San Diego, 1994.
16. GIROS, B., JABER, M., JONES, S. R., WIGHTMAN, R. M. AND CARON, M. G.: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (Lond.) 379: 606-612, 1996.
17. GLICK, S. D., DONG., N., KELLER, R. W., JR. AND CARLSON, J. N.: Estimating extracellular concentrations of dopamine and 3,4-dihydroxyphenylacetic acid in nucleus accumbens and striatum using microdialysis: Relationships between in vitro and in vivo recoveries. J. Neurochem. 62: 2017-2021, 1994.
18. GRATTON, A. AND WISE, R. A.: Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J. Neurosci. 14: 4130-4146, 1994.
19. HALL, M. E., HOFFER, B. J. AND GERHARDT, G. A.: Rapid and sensitive determination of catecholamines in small tissue samples by high performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection. LC/GC 7: 258-265, 1989.
20. HERDON, H., STRUPISH, J. AND NAHORSKI, S. R.: Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: Effects of depolarizing stimuli, amphetamine and synthesis inhibition. Brain Res. 348: 309-320, 1985.
21. HOTCHKISS, A. J., MORGAN, M. E. AND GIBB, J. W.: The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 25: 1373-1378, 1979.
22. KAMETANI, H., IIJIMA, S., SPANGLER, E. L., INGRAM, D. K. AND JOSEPH, J. A.: In vivo assessment of striatal dopamine release in the aged male Fischer 344 rat. Neurobiol. Aging 16: 639-646, 1995.
23. KUCZENSKI, R. AND SEGAL, D. S.: Neurochemistry of amphetamine. In Amphetamine and Its Analogs: Psychopharmacology, Toxicology, and Abuse, ed. by A. K. Cho and D. S. Segal, pp. 81-113, Academic Press, San Diego, 1994.
24. LOREZ, H.: Fluorescence histochemistry indicates damage of striatal dopamine nerve terminals in rats after multiple doses of methamphetamine. Life Sci, 28: 911-916, 1981.
25. LUTHMAN, J., FRIEDEMANN, M., BICKFORD, P., OLSON, L., HOFFER, B. J. AND GERHARDT, G. A.: In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment. Neuroscience 52: 677-687, 1993.
26. MARSHALL, J. F., O'DELL, S. J., NAVARRETE, R. AND ROSENSTEIN, A. J.: Dopamine high-affinity transport site topography in rat brain: Major differences between dorsal and ventral striatum. Neuroscience 37: 11-21, 1990.
27. MARSHALL, J. F. AND ROSENSTEIN, A. J.: Age-related decline in rat striatal dopamine metabolism is regionally homogeneous. Neurobiol. Aging 11: 131-137, 1990.
28. 2 receptors may modulate the function of the striatal transporter for dopamine: Kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61: 764-767, 1993.
29. MILLER, M. A. AND HUGHES, A. L.: Epidemiology of amphetamine use in the United States. In Amphetamine and Its Analogs: Psychopharmacology, Toxicology, and Abuse, ed. by A. K. Cho and D. S. Segal, pp. 439-457, Academic Press, San Diego, 1994.
30. MOGHADDAM, B. AND BUNNEY, B. S.: Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J. Neurochem. 53: 652-654, 1989.
31. O'DELL, S. J., WEIHMULLER, F. B. AND MARSHALL, J. F.: Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564: 256-260, 1991.
32. 2 antagonists. J. Neurochem. 60: 1792-1799, 1993.
33. 2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. J. Neurochem. 60: 376-379, 1993.
34. PU, C. AND VORHEES, C. V.: Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: An immunohistochemical study. Synapse 19: 97-104, 1995.
35. RICAURTE, G. A., GUILLERY, R. W., SEIDEN, L. S., SCHUSTER, C. R. AND MOORE, R. Y.: Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235: 93-103, 1982.
36. RICAURTE, G. A., SCHUSTER, C. R. AND SEIDEN, L. S.: Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res. 193: 153-163, 1960.
37. 3H]GBR 12935: Binding characteristics, Brain Res. 540: 1-13, 1991.
38. ROBINSON, T. E., MOCSARY, Z., CAMP, D. M. AND WHISHAW, I. Q.: Time course of recovery of extracellular dopamine following partial damage to the nigro-striatal dopamine system. J. Neurosci. 14: 2687-2696, 1994.
39. ROBINSON, T. E., YEW, J., PAULSON, P. E. AND CAMP, D. M.: The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with mierodialysis in striatum. Neurosci. Lett. 110: 193-198, 1990.
40. SEIDEN, L. S., COMMINS, D. L., VOSMER, G., AXT, K. AND MAKEK, G.: Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: A regional analysis in nigrostriatal and mesolimbic projections. Ann, N.Y. Acad. Sci. 537: 163-172, 1988.
41. SEIDEN, L. S., FISCHMAN, M. W. AND SCHUSTER, C. R.: Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1: 215-219, 1975/76.
42. SEIDEN, L. S. AND RICAURTE, G. A.: Neurotoxicity of methamphetamine and related drugs. In Psychopharmacology: The Third Generation of Progress, ed. by H. Y. Meltzer, pp. 359-366, Raven Press, New York, 1987.
43. 2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J. Pharmacol. Exp. Ther. 238: 932-937, 1986.
44. STAMFORD, J. A., KRUK, Z. L. AND MILLAR, J.: Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: In vivo voltammetric data. Br. J. Pharmacol, 102: 45-50, 1991.
45. STEPHANS, S. E. AND YAMAMOTO, B. K.: Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux. Synapse 17: 203-209, 1994.
46. SUAUD-CHAGNY, M. F., DUGAST, C., CHERGUI, K., MSGHINA, M. AND GANON, F.: Uptake of dopamine released by impulse flow in the rat mesolimhic and striatal systems in vivo. J. Neuruchem. 65: 2603-2611, 1995.
47. WAGNER, G. A., SEIDEN, L. S. AND SCHUSTER, C. R.: Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. Drup Alcohol Depend. 4: 435-438, 1979.
48. WALSH, S. L. AND WAGNER, G. C.: Motor impairments after metharnphetamine-induced neurotoxicity in the rat. J. Pharmacol. Exp. Ther. 263: 617-626, 1992.
49. WILSON, J. M., KALASINSKY, K. S., LEVEY, A. I., BERGERON, C., REIBER, G., ANTHONY, R. M., SCHMUNK, G. A., SHANNAK, K., HAYCOCK, J. W. AND KISH, S. J.: Striatal dopamine nerve terminal markers in human, chronic methumphetamine users. Nature Med. 2: 699-703, 1996.
50. WOOD, E. R., COURY, A., BLAHA, C. D. AND PHILLIPS, A. G.: Extracellular dopamine in the rat atriatum during ischemia and reperfusion as measured by in vivo electrochemistry and in vivo microdialysis. Brain Res. 591: 151-159, 1992.